Open Access

microRNAs: important regulators of stem cells

Stem Cell Research & Therapy20178:110

DOI: 10.1186/s13287-017-0551-0

Published: 11 May 2017

Abstract

Stem cells are undifferentiated cells and have multi-lineage differentiation potential. Generally, stem cells are classified into adult stem cells, embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). Stem cells have great potential in clinical therapy due to their pluripotency and self-renewal ability. microRNAs (miRNAs) are small non-coding RNAs which are evolutionarily conserved and participate in the pathogenesis of many diseases, cell cycle regulation, apoptosis, aging, cell fate decisions, and different signaling pathways. Different kinds of stem cells possess distinct miRNA expression profiles. Our review summarizes the critical roles of miRNAs in stem cell reprogramming, pluripotency maintenance, and differentiation. In the future, miRNAs may greatly contribute to stem cell clinical therapy and have potential applications in regenerative medicine.

Keywords

Stem cell miRNAs Reprogramming Pluripotency Differentiation

Background

Stem cells are undifferentiated cells and have multi-lineage differentiation potential. Generally, stem cells are classified into adult stem cells, embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). Adult stem cells are named according to the tissue in which they originated, such as mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), cardiac stem cells, neural stem cells (NSCs), endothelial stem cells, etc. ESCs are pluripotent stem cells derived from the inner cell mass of a blastocyst or earlier morula stage embryos in epiblast tissue [1], whereas iPSCs are directly generated through somatic cell reprogramming [2]. Stem cells have great potential in clinical therapy due to their pluripotency and self-renewal ability. In preclinical animal experiments, cardiovascular cells [3], neural cells [4], and osteoblasts [5] differentiated from stem cells have been transplanted to repair damaged organs.

microRNAs (miRNAs) are small non-coding single-stranded RNAs with a length of about 21–22 nucleotides that repress gene expression through translational inhibition or by promoting the degradation of mRNAs. In the nucleus, the transcribed primary miRNAs (pri-miRNAs) are cleaved to form precursor miRNAs (pre-miRNAs) containing short hairpins by the microprocessor, which is composed of RNA-binding protein DGCR8 and RNase III enzyme Drosha. Pre-miRNAs are then exported into the cytoplasm by exportin-5 and finally processed by Dicer to form mature miRNAs [6]. Mature miRNAs are incorporated into the RNA-induced silencing complex (RISC) to regulate gene expression post-transcriptionally by base pairing with the 3′ untranslated region (3′ UTR) of their targets [7]. However, a few miRNAs have been demonstrated to repress gene expression by binding the open reading frame region of the target [8]. Previous studies have demonstrated that miRNAs play critical roles in physiological processes and the pathogenesis of many diseases. In general, miRNAs have great potential for treating various diseases, such as myocardial injury and neurodegenerative, blood, and muscle diseases [912]. Recently, miRNAs are discovered to be important regulators of stem cells. Genetically ablated Dicer −/− or Dgcr8 −/− ESCs show abnormal differentiation [13, 14]. Studies show that miRNAs regulate the state of stem cells by directly targeting the 3′ UTR of pluripotency factors. For instance, miR-145 represses the pluripotency of human ESCs through targeting octamer-binding transcription factor 4 (Oct4; also known as Pou5f1, POU domain, class 5, transcription factor 1), sex determining region Y-box 2 (Sox2), and kruppel-like factor 4 (Klf4) [15]. In addition, miRNAs target the coding regions of transcription factors to modulate stem cell differentiation. miR-296, miR-470, and miR-134 regulate mouse ESC differentiation by targeting the coding regions of Nanog, Oct4, and Sox2 [16]. Other classified miRNAs also regulate the fate of stem cells. Embryonic stem cell-specific (ESCC) miRNAs (also called ESC-specific cell cycle-regulating miRNAs), c-Myc-induced miRNAs, p53-targeting miRNAs, and early embryonic miRNA cluster (EEmiRC) also regulate the self-renewal, reprogramming and differentiation of stem cells [1720].

miRNAs and stem cell reprogramming

Cell reprogramming

Cell reprogramming refers to the process of a differentiated somatic cell being reprogrammed into a pluripotent state or even forming a new individual under particular conditions. Cell reprogramming involves nuclear transplantation and iPSC reprogramming technologies. Nuclear transplantation forms a new individual through transferring a donor somatic nucleus into an enucleated oocyte. The iPSC technologies are used to reprogram somatic cells into pluripotent states through enhanced expression of pluripotency-related genes or proteins [2, 21]. Our review focuses on somatic cell reprogramming.

Somatic cell reprogramming was discovered in 2006. iPSCs are successfully generated from mouse fibroblasts through virus-mediated transfection of Oct3/4, Sox2, Klf4, and c-Myc [2]. Human iPSCs are generated by transduction of the alternative combinations of Oct3/4, Sox2, Nanog, and Lin28 [22]. However, the reprogramming efficiency is about 0.02–0.08% for virus-mediated transduction of pluripotent genes. Since the virus can integrate into the genome randomly, this method carries a high risk of tumorigenicity. Recently, lower tumorigenic iPSCs have been generated. For example, mouse iPSCs were generated through transfection of two plasmids, one containing the complementary DNAs (cDNAs) of Oct3/4, Sox2, and Klf4, and the other containing the c-Myc cDNA. However, the reprogramming efficiency was substantially lower than with the virus-free method [23]. Furthermore, synthetically modified mRNA has been used to generate human iPSCs more efficiently. The reprogramming efficiency is about 1.4% with lower tumorigenicity potential [24].

miRNAs participate in the regulation of stem cell reprogramming

miRNAs regulate the reprogramming efficiency of iPSCs. The ESCC miRNAs enhance reprogramming efficiency. For instance, over-expression of the miR-290 family or miR-302 family enhances reprogramming efficiency [25]. Human miR-372 (an ortholog of the mouse miR-290 cluster and miR-302 cluster), the miR-17-92 cluster, the miR-106b-25 cluster, and the miR-106a-363 cluster (sharing very similar seed sequence with the miR-302 cluster) have been proven to increase reprogramming efficiency [26, 27]. Strikingly, miRNAs can reprogram somatic cells into iPSCs directly. For example, the miR-302 cluster can reprogram human skin cancer cells into a pluripotent state [28]. Also, direct transfection of the mature double-stranded miR-200c, miR-302, and miR-369 family can reprogram mouse and human somatic cells into pluripotent states [29]. miRNA-induced iPSCs have a reprogramming efficiency above 10% and also the lowest tumorigenicity.

Autologous iPSCs can be directly obtained through somatic cell reprogramming and have potential applications in regenerative medicine. Furthermore, use of autologous iPSCs can avoid ethical issues and immunological rejection. However, autologous iPSCs are still assocaited with lower reprogramming efficiency and tumorigenicity. In the future, autologous iPSCs may have great value in regenerative medicine.

Mechanism of miRNA-mediated stem cell reprogramming

miRNAs regulate stem cell reprogramming by regulating the reprogramming process. This process has been divided into three phases: initiation, maturation, and stabilization [30]. The initiation phase exhibits a mesenchymal-to-epithlial transition (MET) character. The miR-200 family (miR-200b and miR-200c), the miR-106a-363 and miR-302-367 cluster, and miR-93/106b, which are activated by OSK (Oct4, Sox2, Klf4) or OSKM (Oct4, Sox2, Klf4, c-myc), can promote the MET process during iPSC initiation [27, 30, 31]. Also, down-regulated miR-30/let-7 family and up-regulated miR-17, miR-19, miR-290, and miR-8 family miRNAs play important roles in the activation and maintenance of pluripotency [30].

Furthermore, miRNAs participate in the reprogramming process by regulating cell cycle factors. For instance, the miR-25 family and miR-130/301/721 family target p21, a cell cycle inhibitor, to promote reprogramming efficiency [27, 32]. Depletion of miR-34a significantly promotes the somatic cell reprogramming process. Studies have found that miR-34a and p21 together regulate reprogramming efficiency by targeting p53 [33]. The regulatory function of miRNAs on stem cell reprogramming is depicted in Additional file 1.

miRNAs and stem cell pluripotency

miRNAs modulate the pluripotency of stem cells, generally regulating the pluripotency factors by directly targeting their 3′ UTRs. miR-145 represses the pluripotency of human ESCs by repressing the expression of Oct4, Sox2, and Klf4 [15]. However, miR-134, miR-296, and miR-470 target the coding sequence of Sox2, Nanog, and Oct4 to regulate the pluripotency of ESCs [16]. A recent study has shown that the miR-290 family affects the pluripotency and differentiation of ESCs through epigenetic regulation of de novo DNA methylation [34]. Another study has shown that Oct4, Sox2, Nanog, and Transcription factor 3 (Tcf3) have binding sites in the promoter region of most miRNAs that are preferentially or exclusively expressed in ESCs. These transcription factors also regulate the expression of miRNAs [35].

miRNAs and stem cell differentiation

Stem cells possess specific miRNA expression profiles which modulate stem cell fate [35]. This mechanism could be used to terminally differentiate cells from stem cells in order to treat various diseases, including myocardial infarction, neurodegenerative diseases, blood diseases, and muscle diseases.

miRNAs and cardiovascular differentiation

miRNAs modulate cardiovascular differentiation of cardiomyocyte progenitor cells and stem cells, including the differentiation of cardiomyocytes, vascular smooth muscle cells (SMCs), and endothelial cells (ECs). On one hand, miR-499 enhances cardiovascular differentiation of human-derived cardiomyocyte progenitor cells by targeting Sox6 [36]; on the other hand, miRNAs regulate the cardiovascular differentiation of ESCs and iPSCs. In the infarcted heart, miR-1 promotes cardiac differentiation of ESCs and inhibits cardiomyocyte apoptosis through the phosphatase and tensin homology deleted on chromosome ten (PTEN)/Akt pathway [37]. miR-1 also promotes SMC differentiation of retinoid acid-induced ESCs by targeting Klf4 [38]. It has been demonstrated that retinoic acid promotes nuclear translocation of NF-κB, which activates the miR-10a expression; miR-10a promotes SMC differentiation from mESCs by targeting histone deacetylase 4 (HDAC4) [39]. Kim and colleagues have shown that miR-6086 and miR-6087 block EC differentiation of human ESCs by inhibiting the expression of CDH5 and endoglin, respectively [40]. In mouse iPSCs, miR-199b promotes EC differentiation by modulating signal transducer and activator of transcription 3 (STAT3)/vascular endothelial growth factor (VEGF) signaling [41]. Depletion of miR-495 promotes EC differentiation and angiogenesis through targeting vascular endothelial zinc finger 1 (VEZF1) in human iPSCs [42]. miRNA-mediated cardiovascular differentiation of stem cells has great therapeutic value in regenerative medicine. The specific function of miRNAs in cardiovascular differentiation is summarized in Additional file 2.

miRNAs and neural differentiation

Previous studies have shown that miRNAs also play critical roles in neurogenesis. Doetsch and colleagues reported that miR-124 promotes the neural differentiation of the subventricular zone, which is the largest neurogenic niche in adult mammalian brain [43]. Forced expression of miR-34a results in reduction of dendritic length, neuron branch numbers, and the numbers of functional synapses and disruption of inhibitory inputs [44]. miRNAs also regulate NSC differentiation through regulatory loops. miR-9 promotes NSC differentiation by targeting the nuclear receptor TLX, which inhibits the expression of pri-miR-9. TLX and miR-9 form a negative regulatory loop balancing the proliferation and differentiation of NSCs [45]. Furthermore, acute deficiency of Methy-CpG binding protein1 (MBD1) results in increased miR-184, which directly targets the brain development regulator Numblike (Numbl). MBD1-miR-184-Numbl forms a loop to regulate adult NSC differentiation [46].

More importantly, miRNAs regulate the neurogenesis of ESCs and iPSCs through targeting relative neural differention genes. miR-371-3 is highly expressed in human iPSCs and ESCs. Suppression of miR-371-3 promotes neural differentiation [47]. Down-regulation of miR-132 promotes the differentiation of tyrosine hydroxylase-positive neurons by suppressing Nurr1 [48]. Knockdown of Smad4 in human ESCs increases the percentage of the neural lineage commitment. miR-125, which is activated by inhibition of both the activin and BMP-dependent pathways, can promote human ESC differentiation towards the neural lineage through suppression of Smad4 [49]. NR2F2 (nuclear receptor subfamily 2, group F, member 2) is necessary for neural differentiation in human ESCs. Oct4 and miR-302 can form a regulation loop during neural differentiation by interacting with NR2F2 [50]. The function of miRNAs in neural differentiation is illustrated in Additional file 3.

miRNAs modulate osteogenic and chondrogenic differentiation of stem cells

Regeneration of osteogenic and chondrogenic cells shows great medical research value. Substantial progress has been made in generating osteogenic and chondrogenic cells from adult stem cells. miRNAs regulate the osteogenic and chondrogenic differentiation through targeting significant transcriptional factors and relative pathways during skeletal development. The ERK-dependent pathway plays a critical role in osteoblast differentiation. It can activate the phosphorylation of runt related transcription factor 2 (RUNX2), promote Osterix expression, and improve the activity of alkaline phosphatase. The focal adhesion kinase (FAK) is linked with the activation of ERK1/2 through extracellular matrix proteins. miR-138 suppresses differentiation of human MSCs into osteoblasts by directly targeting FAK and downstream signaling [51]. miR-23b induces chondrogenic differentiation of human MSCs by suppressing protein kinase A (PKA) signaling [52]. Over-expression of miR-335-5p significantly promotes the chondrogenic differentiation of mouse MSCs by targeting Dishevelled-associated activator of morphogenesis 1(Daam1) and rho-associated coiled-coil containing protein kinase 1 (ROCK1) [53]. Mechanisms by which miRNAs regulate the osteogenic and chondrogenic differentiation of stem cells is summarized in Additional file 4.

miRNAs regulate hematopoietic differentiation of stem cells

miRNAs are key regulators of hematopoiesis in mammalians. Erkeland and colleagues discovered that ectopic expression of AAAGUGC seed-containing miRNAs enhance the primary hematopoietic progenitors [54]. Bartel and colleagues were the first to show that miR-181, miR-223, and miR-142 cloned from mouse bone marrow are preferentially expressed in hematopoietic tissues. miR-181 significantly promotes B-lymphocyte differentiation [55]. miRNAs also play a significant role during the proliferation and differentiation of HSCs. miR-125a is conservatively expressed in long-term HSCs and can increase the number of HSCs by targeting the apoptosis factor Bax1 [56]. Furthermore, overexpression of miR-125b leads to lethal myeloid leukemia in mice [57].

Conclusions

Stem cells have great clinical value. Adult stem cells are currently used in clinical tissue and organ repair, which having the advantages of broad sources, no transplant rejection and lower tumorigenicity. ESCs have the ability to differentiate into various types of cells but applications are limited because of higher tumorigenicity and ethical restrictions. iPSCs can provide autologous somatic cells for transplantation that avoid the problems of ethical issues and transplant rejection. Recently, miRNA-mediated reprogramming technology has been discovered. miRNA-induced iPSCs have advantages of higher reprogramming efficiency and lower tumorigenicity. Although no clinical therapy using them has been performed so far, they may greatly aid the development of regenerative medicine in the future. We believe that stem cells will be highly beneficial for regenerative medicine.

miRNAs play critical roles in reprogramming process, pluripotency maintenance, and differentiation of stem cells. Our work focuses on the regulatory function of miRNAs in adult stem cells, ESCs, and iPSCs (Table 1). miRNAs regulate stem cell fate through targeting specific pluripotency factors or differentiation pathways. However, the exact mechanisms of the regulatory functions of miRNAs need to be elucidated and whether other molecules or mechanisms are involved remains to be explored. Moreover, the significant function of miRNAs in the determination of stem cell fate indicates the way miRNAs regulate mammalian development in vivo [58]. miRNAs may be developed as therapeutic targets. Whether mimics or antagomirs of specific miRNAs can be developed as treatments still needs further studies. For example, suppression of miR-371-3 could be used to promote neural differentiation. However, whether the miR-371-3 antagomir could cure neurodegenerative diseases in vivo needs to be elucidated. Research on the regulatory functions of miRNAs will contribute to stem cell-based clinical therapy and also to potential applications in regenerative medicine.
Table 1

miRNAs involved in the regulation of stem cell fate

mRNA

Function

Target/pathway

Reference

miRNA-29a

Regulates chondrogenic differentiation and cartilage formation

FOXO3A

[8]

microRNA-145

Represses pluripotency in human ESCs

Oct4, Sox2, Klf4

[15]

miR-296, mir-470 and miR-134

Regulate mouse ESC differentiation

Nanog, Oct4, Sox2

[16]

miR-290 family or miR-302 family

Enhances reprogramming efficiency

Oct4, Sox2, Klf4

[25]

Human miR-372

Improves reprogramming efficiency

 

[26]

miR-17-92 cluster, miR-106b-25 cluster, miR-106a-363 cluster

Improve reprogramming efficiency

TGF-βR2, p21

[27]

miR-302 cluster

Induces the pluripotent state in human skin cancer cells

 

[28]

Mature double-stranded miR-200c plus miR-302 and miR-369 family

Reprogram mouse and human somatic cells into pluripotent states

 

[29]

miR-200 family, miR-106a-363 and miR-302-367 cluster, miR-93/106b

Promote the MET process of the iPSC initiation phase

 

[27, 30, 31]

Down-regulated miR-30/let-7 family

Activate the pluripotent state

 

[30]

Up-regulated miR-17, miR-19, miR-290 and miR-8 family

Maintain the pluripotent state

 

[30]

miR-25 family and the miR-130/301/721 family

Promote reprogramming efficiency

p21

[27, 32]

miR-34a

Regulates reprogramming efficiency with p21

p53

[33]

miR-290 family

Regulates pluripotency and differentiation

Epigenetic regulation of de novo DNA methylation

[34]

miR-1

Promotes the cardiovascular differentiation of ESCs and inhibits cardiomyocyte apoptosis

PTEN/Akt pathway

[37]

miR-1

Promotes SMCs differentiation of retinoid acid-induced ESCs

Klf4

[38]

miR-10a

Promotes differentiation of mouse ESCs into SMCs

HDAC4

[39]

miR-6086 and miR-6087

Block differentiation of human ESCs into ECs

CDH5, endoglin

[40]

miR-199b

Promotes EC differentiation

 

[41]

Depletion of miR-495

Promotes EC differentiation and angiogenesis of human iPSCs

VEZF1

[42]

miR-9

Promotes NSC differentiation

Balancing the proliferation and differentiation of NSCs with TLX

[45]

miR-184

MBD1-miR-184-Numbl form a loop to regulate adult NSC differentiation

Numbl

[46]

Suppression of miR-371-3

Promotes neural differentiation

 

[47]

Downregulation of miR-132

Promotes the differentiation of tyrosine hydroxylase-positive neurons

Nurr1

[48]

miR-125

Promoted human ESC differentiation towards the neural lineage

Smad4

[49]

miR-302

Forms a regulation loop with OCT4 during neural differentiation

Interacting with NR2F2

[50]

miR-138

Suppresses osteoblast differentiation of human MSCs

Targeting FAK and downstream signaling

[51]

miR-23b

Induces chondrogenic differentiation of hMSCs

By suppressing PKA signaling

[52]

miR-335-5p

Promotes the chondrogenic differentiation of mouse MSCs

Daam1 and ROCK1

[53]

miR-181

Promotes B-lymphocytes differentiation

 

[55]

miR-125a

Increases the number of HSCs

Bax1

[56]

miR-125b

Leads to a lethal myeloid leukemia in mice

 

[57]

miRNAs regulate the reprogramming, pluripotency, and differentiation of stem cells

Abbreviations

EC: 

Endothelial cell

ESC: 

Embryonic stem cell

ESCC: 

Embryonic stem cell-specific

FAK: 

Focal adhesion kinase

HSC: 

Hematopoietic stem cell

iPSC: 

Induced pluripotent stem cell

MET: 

Mesenchymal-to-epithlial transition

miRNA: 

microRNA

MSC: 

Mesenchymal stem cell

NSC: 

Neural stem cell

OSK: 

Oct4, Sox2, Klf4

OSKM: 

Oct4, Sox2, Klf4, c-Myc

PKA: 

Protein kinase A

pre-miRNA: 

Precursor miRNA

pri-miRNA: 

primary miRNA

SMC: 

Smooth muscle cell

UTR: 

Untranslated region.

Declarations

Acknowledgements

We thank Professor Peifeng Li and associate professor Kun Wang. The authors wish to thank the National Natural Science Foundation of China (81470522, 81522005).

Funding

National Natural Science Foundation of China (81470522, 81522005).

Availability of data and materials

Not applicable.

Authors’ contributions

NL conceptualized the study, performed the literature search, and drafted most of the manuscript. BL, WH, and SY wrote the section on miRNAs and stem cell reprogramming. KW revised the article, directed the review to be more focused, and gave final approval for the article to be published. All authors read and approved the manuscript.

Authors’ information

Na Li and Bo Long are PhDs of the Institute of Zoology. Wei Han and Shumin Yuan were post-docs at the Institute of Zoology. Kun Wang is the associate professor of the research group.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences
(2)
Beijing Anzhen Hospital, Capital Medical University
(3)
Guilin Medical University

References

  1. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292:154–6.View ArticlePubMedGoogle Scholar
  2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76.View ArticlePubMedGoogle Scholar
  3. Weinberger F, et al. Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells. Sci Transl Med. 2016;8(363):363ra148.View ArticlePubMedGoogle Scholar
  4. Zhang Q, et al. Stem cells for modeling and therapy of Parkinson’s disease. Hum Gene Ther. 2017;28(1);85–98.View ArticlePubMedGoogle Scholar
  5. Sheyn D, et al. Human iPSCs differentiate into functional MSCs and repair bone defects. Stem Cells Transl Med. 2016;5(11):1447–1460.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Lund E, et al. Nuclear export of microRNA precursors. Science. 2004;303(5654):95–8.View ArticlePubMedGoogle Scholar
  7. Lai EC. MicroRNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet. 2002;30(4):363–4.View ArticlePubMedGoogle Scholar
  8. Guerit D, et al. FOXO3A regulation by miRNA-29a Controls chondrogenic differentiation of mesenchymal stem cells and cartilage formation. Stem Cells Dev. 2014;23(11):1195–205.View ArticlePubMedGoogle Scholar
  9. Barwari T, Joshi A, Mayr M. MicroRNAs in cardiovascular disease. J Am Coll Cardiol. 2016;68(23):2577–84.View ArticlePubMedGoogle Scholar
  10. Marques TM, et al. MicroRNAs in cerebrospinal fluid as potential biomarkers for Parkinson’s disease and multiple system atrophy. Mol Neurobiol. 2016.
  11. Choi J, et al. MicroRNA-139-5p regulates proliferation of hematopoietic progenitors and is repressed during BCR-ABL-mediated leukemogenesis. Blood. 2016;128(17):2117–29.View ArticlePubMedGoogle Scholar
  12. Simionescu-Bankston A, Kumar A. Noncoding RNAs in the regulation of skeletal muscle biology in health and disease. J Mol Med (Berl). 2016;94(8):853–66.View ArticleGoogle Scholar
  13. Melton C, Judson RL, Blelloch R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature. 2010;463(7281):621–6.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Kanellopoulou C, et al. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev. 2005;19(4):489–501.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Xu N, et al. MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell. 2009;137(4):647–58.View ArticlePubMedGoogle Scholar
  16. Tay Y, et al. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature. 2008;455(7216):1124–8.View ArticlePubMedGoogle Scholar
  17. Wang Y, et al. Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet. 2008;40(12):1478–83.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Lin CH, et al. Myc-regulated microRNAs attenuate embryonic stem cell differentiation. EMBO J. 2009;28(20):3157–70.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Neveu P, et al. MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states. Cell Stem Cell. 2010;7(6):671–81.View ArticlePubMedGoogle Scholar
  20. Tata PR, et al. Identification of a novel epigenetic regulatory region within the pluripotency associated microRNA cluster, EEmiRC. Nucleic Acids Res. 2011;39(9):3574–81.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Boland MJ, et al. Adult mice generated from induced pluripotent stem cells. Nature. 2009;461(7260):91–4.View ArticlePubMedGoogle Scholar
  22. Yu J, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917–20.View ArticlePubMedGoogle Scholar
  23. Okita K, et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science. 2008;322:949–53.View ArticlePubMedGoogle Scholar
  24. Warren L, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7(5):618–30.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Judson RL, et al. Embryonic stem cell–specific microRNAs promote induced pluripotency. Nat Biotechnol. 2009;27(5):459–61.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Subramanyam D, et al. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol. 2011;29:443–9.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Li Z, et al. Small RNA-mediated regulation of iPS cell generation. EMBO J. 2011;30(5):823–34.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Lin SL, et al. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA. 2008;14(10):2115–24.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Miyoshi N, et al. Reprogramming of mouse and human cells to pluripotency using mature MicroRNAs. Cell Stem Cell. 2011;8(6):633–8.View ArticlePubMedGoogle Scholar
  30. Samavarchi-Tehrani P, et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell. 2010;7(1):64–77.View ArticlePubMedGoogle Scholar
  31. Liao B, et al. MicroRNA cluster 302-367 enhances somatic cell reprogramming by accelerating a mesenchymal-to-epithelial transition. J Biol Chem. 2011;286(19):17359–64.View ArticlePubMedPubMed CentralGoogle Scholar
  32. Pfaff N, et al. miRNA screening reveals a new miRNA family stimulating iPS cell generation via regulation of Meox2. EMBO Rep. 2011;12(11):1153–9.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Choi YJ, et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol. 2011;13(11):1353–60.View ArticlePubMedPubMed CentralGoogle Scholar
  34. Sinkkonen L, et al. MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat Struct Mol Biol. 2008;15(3):259–67.View ArticlePubMedGoogle Scholar
  35. Marson A, et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell. 2008;134(3):521–33.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Sluijter JP, et al. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol. 2010;30(4):859–68.View ArticlePubMedGoogle Scholar
  37. Glass C, Singla DK. MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart. Am J Physiol Heart Circ Physiol. 2011;301(5):H2038–49.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Xie C, et al. MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells Dev. 2011;20(2):205–10.View ArticlePubMedGoogle Scholar
  39. Huang H, et al. miR-10a contributes to retinoid acid-induced smooth muscle cell differentiation. J Biol Chem. 2010;285(13):9383–9.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Yoo JK, et al. Discovery and characterization of novel microRNAs during endothelial differentiation of human embryonic stem cells. Stem Cells Dev. 2012;21(11):2049–57.View ArticlePubMedGoogle Scholar
  41. Chen T, et al. MicroRNA-199b modulates vascular cell fate during iPS cell differentiation by targeting the Notch ligand Jagged1 and enhancing VEGF signaling. Stem Cells. 2015;33(5):1405–18.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Liang J, et al. Inhibition of microRNA-495 enhances therapeutic angiogenesis of human induced pluripotent stem cells. Stem Cells. 2017;35(2):337–350.View ArticlePubMedGoogle Scholar
  43. Cheng LC, et al. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci. 2009;12(4):399–408.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Agostini M, et al. microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc Natl Acad Sci U S A. 2011;108(52):21099–104.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Zhao C, et al. A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat Struct Mol Biol. 2009;16(4):365–71.View ArticlePubMedPubMed CentralGoogle Scholar
  46. Liu C, et al. Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation. Cell Stem Cell. 2010;6(5):433–44.View ArticlePubMedPubMed CentralGoogle Scholar
  47. Kim H, et al. miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells. Cell Stem Cell. 2011;8(6):695–706.View ArticlePubMedGoogle Scholar
  48. Yang D, et al. miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression. J Cell Sci. 2012;125(Pt 7):1673–82.View ArticlePubMedGoogle Scholar
  49. Boissart C, et al. miR-125 potentiates early neural specification of human embryonic stem cells. Development. 2012;139(7):1247–57.View ArticlePubMedGoogle Scholar
  50. Rosa A, Brivanlou AH. A regulatory circuitry comprised of miR-302 and the transcription factors OCT4 and NR2F2 regulates human embryonic stem cell differentiation. EMBO J. 2011;30(2):237–48.View ArticlePubMedGoogle Scholar
  51. Eskildsen T, et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci U S A. 2011;108(15):6139–44.View ArticlePubMedPubMed CentralGoogle Scholar
  52. Ham O, et al. The role of microRNA-23b in the differentiation of MSC into chondrocyte by targeting protein kinase A signaling. Biomaterials. 2012;33(18):4500–7.View ArticlePubMedGoogle Scholar
  53. Lin X, et al. MiR-335-5p promotes chondrogenesis in mouse mesenchymal stem cells and is regulated through two positive feedback loops. J Bone Miner Res. 2014;29(7):1575–85.View ArticlePubMedGoogle Scholar
  54. Meenhuis A, et al. MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in mice. Blood. 2011;118(4):916–25.View ArticlePubMedPubMed CentralGoogle Scholar
  55. Chen CZ, et al. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303(5654):83–6.View ArticlePubMedGoogle Scholar
  56. Guo S, et al. MicroRNA miR-125a controls hematopoietic stem cell number. Proc Natl Acad Sci U S A. 2010;107(32):14229–34.View ArticlePubMedPubMed CentralGoogle Scholar
  57. O’Connell RM, et al. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc Natl Acad Sci U S A. 2010;107(32):14235–40.View ArticlePubMedPubMed CentralGoogle Scholar
  58. Shah AA, Meese E, Blin N. Profiling of regulatory microRNA transcriptomes in various biological processes: a review. J Appl Genet. 2010;51(4):501–7.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement